Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-06-22A Phase 1 Study to Evaluate the Safety and Tolerability of Anti-PD-L1, MEDI4736, in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-06-18Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
-
CLINICAL_TRIALS study record update · 2020-06-17A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-06-12A Phase II Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 Cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression.
-
CLINICAL_TRIALS study record update · 2020-06-09FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-05-29A Phase III Clinical Trail of Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-05-28A Phase Ib/II Study of CRLX101 in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-05-22Diaphragmatic Resection And Gynecological Ovarian Neoplasm
-
CLINICAL_TRIALS study record update · 2020-05-18Multicenter Prospective Randomized Controlled Clinical Trial of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After Primary Cytoreductive Surgery
-
CLINICAL_TRIALS study record update · 2020-05-12A Phase 2 Randomized, Open-label, Multicenter Trial of Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant or Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-05-06Cancer Screening and Prevention Program for High Risk Women
-
CLINICAL_TRIALS study record update · 2020-05-04Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-04-29The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
-
CLINICAL_TRIALS study record update · 2020-04-20Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers
-
CLINICAL_TRIALS study record update · 2020-04-16WISER After Ovarian Cancer - Exercise Pilot Study
-
CLINICAL_TRIALS study record update · 2020-04-09A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
-
CLINICAL_TRIALS study record update · 2020-04-08A Phase II Study Of OSI-774 (NSC 718781) Given In Combination With Carboplatin In Patients With Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-07VM110 in Detection of Microscopic Tumors: A Phase I Study
-
CLINICAL_TRIALS study record update · 2020-04-06A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-04-06Randomized Phase II Study Of NX 211 Given By Two Different Intravenous Schedules In Advanced And/Or Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-06Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-02Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
-
CLINICAL_TRIALS study record update · 2020-04-02A Phase III Study of Cisplatin Plus Topotecan Followed by Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women With Newly Diagnosed Advanced Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-02Access to Fast Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-04-01Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.